Science Explorer Back to mapMap
Discussion
Institution · Bellinzona · Switzerland

International Extranodal Lymphoma Study Group

ielsg.orgROR OpenAlex
Research works
9
▲ 151% vs 2018-21
Citations
718
83.9 per fractional work
Top-10% rate
47.4%
all institutions 10.0%
Open access
31%
world 40%
International
31%
world 18%
International Extranodal Lymphoma Study Group

Not ranked overall: International Extranodal Lymphoma Study Group is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does International Extranodal Lymphoma Study Group work in?

In all years, 84% of research at International Extranodal Lymphoma Study Group is in Health Sciences, 12% in Life Sciences. Its largest fields are Medicine (84%), Immunology and Microbiology (6%), Agricultural and Biological Sciences (4%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 84.4% of its workMedicine: 7 fractional works · 84.4% of its workPathology and Forensic Medicine: 3 fractional works · 37.0% of its workNeurology: 1 fractional works · 11.7% of its workGenetics: 1 fractional works · 9.2% of its workSurgery: 1 fractional works · 6.7% of its workOncology: 1 fractional works · 6.4% of its workDermatology: 1 fractional works · 6.0% of its workGastroenterology: 0 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.3% of its workHepatology: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.2% of its workLife Sciences: 1 fractional works · 11.7% of its workImmunology and Microbiology: 0 fractional works · 5.8% of its workImmunology: 0 fractional works · 5.8% of its workAgricultural and Biological Sciences: 0 fractional works · 3.9% of its workInsect Science: 0 fractional works · 2.6% of its workPlant Science: 0 fractional works · 1.3% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 2.0% of its workCancer Research: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.6% of its workMolecular Biology: 0 fractional works · 0.6% of its workPhysical Sciences: 0 fractional works · 3.9% of its workMaterials Science: 0 fractional works · 3.9% of its workMaterials Chemistry: 0 fractional works · 3.9% of its workALL ITS WORKInternationalExtranodal…9fractional works, all years
Life Sciences12%Physical Sciences4%Health Sciences84%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine784.4%
    1. Immunology and Microbiology05.8%
    2. Agricultural and Biological Sciences03.9%
    3. Biochemistry, Genetics and Molecular Biology02.0%
    1. Materials Science03.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from International Extranodal Lymphoma Study Group?

The most cited paper from International Extranodal Lymphoma Study Group is "Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue" (Emanuele Zucca, Annarita Conconi, E Pedrinis et al., 2003), with 490 citations. Next come "Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report" (293) and "Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial" (173).

Most cited papers
#PaperReleasedCitations
1 Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue Emanuele Zucca, Annarita Conconi, E Pedrinis et al. · Blood 17 Mar 2003 490
2 Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report Sean Aaron Grimm, José S. Pulido, Kristoph Jahnke et al. · Annals of Oncology Open access 5 Sep 2007 293
3 Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial Andrés J.M. Ferreri et al. · Leukemia Open access 13 May 2022 173
4 Marginal-Zone Lymphomas Davide Rossi, Francesco Bertoni, Emanuele Zucca · New England Journal of Medicine 9 Feb 2022 163
5 MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial Andrés J.M. Ferreri et al. · The Lancet Haematology Open access 26 Jan 2021 108
All 36 most cited papers, with filters and sorting

Which research topics does International Extranodal Lymphoma Study Group publish most on?

By volume in 2022-now: Lymphoma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Galectins and Cancer Biology.

Lymphoma Diagnosis and T…1Lymphoma Diagnosis and Treatment: 1 fractional worksCNS Lymphoma Diagnosis a…0CNS Lymphoma Diagnosis and Treatment: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksGalectins and Cancer Biology: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional worksCutaneous lymphoproliferative disorders research: 0 fractional worksViral-associated cancers and disorders: 0 fractional works
Pathology and Forensic MedicineNeurologyGeneticsImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  2. 2 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Galectins and Cancer Biology Immunology 0 works
  5. 5 Glioma Diagnosis and Treatment Genetics 0 works
  6. 6 Cutaneous lymphoproliferative disorders research Dermatology 0 works
  7. 7 Viral-associated cancers and disorders Oncology 0 works
  8. 8 Multiple and Secondary Primary Cancers Epidemiology 0 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 0 works
  10. 10 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.1%not open68.9%

World: 40% of research is openly available.

with international co-authors31.2%domestic only68.8%

World: 18% is written across borders.

How has International Extranodal Lymphoma Study Group's research output changed?

Output in 2022-2025 was 151% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is International Extranodal Lymphoma Study Group as a percentage of every work published that year, 0.00000054% in 2024.

still counting0.000020%0.000040%0.000060%International Extranodal Lymphoma Study Group0.0000036% in 202520102020

Fractional works of International Extranodal Lymphoma Study Group over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bellinzona

All research institutions in Bellinzona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about International Extranodal Lymphoma Study Group. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.